27 completed. 27 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 27 | Completed 27 |
| Phase 2 | 3 | Completed 3 |
Follow Hyperphagia: new trials by email Literature Review of Hyperphagia trials Research Report on Hyperphagia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition NTCB01-1, NTCB-P - Parenteral Nutrition | Phase 3 | Completed | Yuhan Corporation | 60 | 2024-11-14 | 2025-05-15 |
| Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Peri Inj. Compared With RPN301 IN-C006 Peri inj., RPN301 - Parenteral Nutrition | Phase 3 | Completed | HK inno.N Corporation | 59 | 2022-08-09 | 2023-09-28 |
| Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301 IN-C006 inj., RCN301 - Parenteral Nutrition | Phase 3 | Completed | HK inno.N Corporation | 60 | 2022-05-04 | 2023-09-28 |
| EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway Setmelanotide, Placebo - Obesity, Genetic Obesity | Phase 3 | Completed | Rhythm Pharmaceuticals, Inc. | 296 | 2022-04-26 | 2026-11-12 |
| Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway Setmelanotide 2 mg, Setmelanotide 2.5 mg, Setmelanotide 3 mg - Bardet-Biedl Syndrome, POMC Deficiency | Phase 3 | Completed | Rhythm Pharmaceuticals, Inc. | 19 | 2021-12-21 | 2024-11-26 |
| Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition SmofKabiven emulsion for infusion, Hospital compounded "All in one" emulsion - Parenteral Nutrition, Surgery | Phase 3 | Completed | Fresenius Kabi | 273 | 2019-01-03 | 2021-08-02 |
| Omegaven as Alternative Parenteral Fat Nutrition Omegaven - Cholestasis, Cholestasis of Parenteral Nutrition | Phase 3 | Completed | University of South Florida | 2 | 2018-10-23 | 2020-07-22 |
| Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition Teduglutide 0.05mg/kg, Teduglutide 0.025 mg/kg, Standard of Care - Short Bowel Syndrome | Phase 3 | Completed | Shire | 59 | 2016-06-23 | 2021-06-09 |
| Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition multicomponent lipid emulsion, pure soybean oil lipid emulsion - Cholestasis | Phase 3 | Completed | Thammasat University | 44 | 2013-12-01 | 2017-06-23 |
| A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021 Teduglutide - Short Bowel Syndrome | Phase 3 | Completed | Shire | 14 | 2012-05-21 | 2021-06-10 |
| Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation Oliclinomel N4, Compounded ternary parenteral nutrition admixtures - Nutrition Support | Phase 3 | Completed | Baxter Healthcare Corporation | 458 | 2011-12-01 | 2013-02-01 |
| Efficacy and Safety of a Fish Oil Containing Lipid Emulsion fish oil containing lipid emulsion, MCT/LCT containing lipid emulsion - Parenteral Nutrition | Phase 3 | Completed | B. Braun Melsungen AG | 240 | 2010-04-01 | 2012-01-10 |
| Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS) teduglutide - Short Bowel Syndrome | Phase 3 | Completed | Shire | 88 | 2009-09-21 | 2021-06-11 |
| Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects teduglutide, placebo - Short Bowel Syndrome | Phase 3 | Completed | Shire | 86 | 2008-11-25 | 2021-06-03 |
| Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN ClinOleic 20% Intravenous Emulsion, Intralipid, 20% Intravenous Emulsion - Parenteral Nutrition | Phase 2 / Phase 3 | Completed | Emory University | 100 | 2008-11-01 | 2018-10-17 |
| Safety During Use of Paediatric Triple Chamber Bag Formulas Ped3CB - Infant Nutrition Disorders, Infant, Premature, Diseases | Phase 3 | Completed | Baxter Healthcare Corporation | 161 | 2008-02-01 | 2011-02-25 |
| Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition SMOF lipid and Intralipid - Parenteral Nutrition | Phase 3 | Completed | Fresenius Kabi | 75 | 2007-10-01 | 2010-08-27 |
| The AOT (Acridine Orange and Taurolidine) Trial taurolidine - Parenteral Nutrition, Infection | Phase 3 | Completed | Radboud University Medical Center | 60 | 2006-06-01 | 2009-02-11 |
| Craving, Binge Eating and Obesity bupropion, Placebo - Binge Eating Disorder, Obesity | Phase 2 / Phase 3 | Completed | Yale University | 61 | 2005-12-01 | 2020-04-03 |
| Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery a combination of MCT, LCT , and Fish Oil - Inflammation, Cardiac Surgical Procedures | Phase 2 / Phase 3 | Completed | University of Alberta | 32 | 2005-11-01 | 2007-11-27 |
Showing 20 of 27. Sign in to see all of them.
Short Bowel Syndrome (6) · Bulimia (3) · Obesity (3) · Premature Birth (3) · Binge-Eating Disorder (2) · Cholestasis (2) · Sepsis (2) · Bardet-Biedl Syndrome (1) · Cross Infection (1) · Digestive System Diseases (1) · Emotional Eating (1) · Feeding and Eating Disorders (1) · Infant Nutrition Disorders (1) · Infant, Premature, Diseases (1)
Pathological Conditions, Signs and Symptoms (27) · Signs and Symptoms (27) · Signs and Symptoms, Digestive (27) · Pathologic Processes (10) · Digestive System Diseases (8) · Gastrointestinal Diseases (6) · Intestinal Diseases (6) · Malabsorption Syndromes (6) · Nutritional and Metabolic Diseases (6) · Postoperative Complications (6) · Nutrition Disorders (5) · Body Weight (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Mental Disorders (3)
teduglutide (6) · ALX-0600 (5) · soybean oil, phospholipid emulsion (4) · fish oil triglycerides (2) · setmelanotide (2) · Bupropion (1) · ClinOleic (1) · Fat Emulsions, Intravenous (1) · Fish Oils (1) · Glutamine (1) · Parenteral Nutrition (1) · Rimonabant (1) · Standard of Care (1) · Topiramate (1) · amino-acid, glucose, and electrolyte solution (1)
Shire (6) · Baxter Healthcare Corporation (2) · Fresenius Kabi (2) · HK inno.N Corporation (2) · Rhythm Pharmaceuticals, Inc. (2) · B. Braun Melsungen AG (1) · Emory University (1) · Janssen-Cilag Farmaceutica Ltda. (1) · NICHD Neonatal Research Network (1) · Pediatrix (1) · Radboud University Medical Center (1) · Sanofi (1) · Sino-Swed Pharmaceutical Corporation (1) · Thammasat University (1) · University of Alberta (1)
United States (14) · Canada (8) · France (8) · Netherlands (8) · United Kingdom (8) · Germany (6) · Denmark (5) · Poland (5) · Belgium (4) · China (4) · Italy (3) · South Korea (3) · Spain (3) · Finland (2) · Israel (2)
David Meeker, MD (2) · Abbot R. Laptook, MD (1) · Avroy A. Fanaroff, MD (1) · Barbara J. Stoll, MD (1) · Brenda B. Poindexter, MD MS (1) · Charles R. Bauer, MD (1) · David K. Stevenson, MD (1) · Edward F. Donovan, MD (1) · Geert Wanten, MD, PhD (1) · Guillermo Umpierrez, MD (1) · Jacques Rigo, MD, PhD (1)
PMID 33006765, PMID 21317170, PMID 24134154, PMID 27507402, PMID 12600870, PMID 15121931, PMID 16099790, PMID 16356432, PMID 16615955, PMID 16818526, PMID 17908750, PMID 17915969, PMID 18055678, PMID 18059467, PMID 18288119, PMID 18716628, PMID 19403482, PMID 20061070, PMID 20473991, PMID 20531018, PMID 22136963, PMID 22237883, PMID 22488002, PMID 22982184, PMID 23147209, PMID 23274148, PMID 23333663, PMID 23587733, PMID 23656848, PMID 29174926, PMID 29761915, PMID 31784300, PMID 32341691, PMID 37889619, PMID 39561769
2004 (2), 2008 (1), 2009 (1), K23DK071646 (1), M01RR000070 (1), M01RR000750 (1), M01RR000997 (1), M01RR001032 (1), M01RR006022 (1), M01RR008084 (1), U01HD036790 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1)